XTL BIOPHARMACEUTICALS LTD.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $3.6M | $3.6M |
| FY2021 | — | $5.3M | $3.0M |
| FY2022 | — | $4.0M | $2.1M |
| FY2023 | — | $2.2M | $1.4M |
| FY2024 | — | $5.4M | $371.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $3.6M | $3.6M |
| FY2021 | — | $5.3M | $3.0M |
| FY2022 | — | $4.0M | $2.1M |
| FY2023 | — | $2.2M | $1.4M |
| FY2024 | — | $5.4M | $371.0K |